FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,942 | -86.5% | 916 | -69.6% | 0.00% | – |
| Q2 2023 | $14,356 | +1674.5% | 3,016 | +2023.9% | 0.00% | – |
| Q1 2023 | $809 | -99.0% | 142 | -98.3% | 0.00% | – |
| Q4 2022 | $83,314 | -60.5% | 8,257 | -12.1% | 0.00% | – |
| Q3 2022 | $211,000 | -17.9% | 9,397 | -9.2% | 0.00% | – |
| Q2 2022 | $257,000 | -1.2% | 10,345 | +53.6% | 0.00% | – |
| Q1 2022 | $260,000 | -22.6% | 6,737 | +17.1% | 0.00% | – |
| Q4 2021 | $336,000 | +40.0% | 5,751 | +42.0% | 0.00% | – |
| Q3 2021 | $240,000 | -31.6% | 4,051 | +0.4% | 0.00% | – |
| Q2 2021 | $351,000 | +31.5% | 4,033 | +24.7% | 0.00% | – |
| Q1 2021 | $267,000 | +56.1% | 3,233 | +72.9% | 0.00% | – |
| Q4 2020 | $171,000 | -20.8% | 1,870 | -65.6% | 0.00% | – |
| Q3 2020 | $216,000 | +16.1% | 5,430 | 0.0% | 0.00% | – |
| Q2 2020 | $186,000 | +45.3% | 5,430 | -6.4% | 0.00% | – |
| Q1 2020 | $128,000 | -26.4% | 5,800 | -34.7% | 0.00% | – |
| Q4 2019 | $174,000 | -1.1% | 8,880 | -22.0% | 0.00% | – |
| Q3 2019 | $176,000 | -20.0% | 11,380 | +4.8% | 0.00% | – |
| Q2 2019 | $220,000 | +15.8% | 10,860 | 0.0% | 0.00% | – |
| Q1 2019 | $190,000 | +8.0% | 10,860 | -20.4% | 0.00% | – |
| Q4 2018 | $176,000 | +15.8% | 13,640 | +45.4% | 0.00% | – |
| Q3 2018 | $152,000 | +26.7% | 9,380 | -10.8% | 0.00% | – |
| Q2 2018 | $120,000 | +1100.0% | 10,520 | +952.0% | 0.00% | – |
| Q1 2014 | $10,000 | +66.7% | 1,000 | 0.0% | 0.00% | – |
| Q4 2013 | $6,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |